STOCK TITAN

Know Labs (KNW) 10-Q Filings

KNW NYSE

Ticker history: KNW became USBC (USBC, Inc.) on .

Here are the 10-Q quarterly reports from Know Labs, Inc. (KNW) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow KNW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KNW filings page.

Rhea-AI Summary

Know Labs, Inc. (KNW) Q3-FY25 10-Q highlights

Cash fell to $172k (Sep-24: $3.1 m) while current liabilities remain $5.1 m, producing a $5.0 m working-capital deficit. Equity is negative $4.8 m and the accumulated deficit widened to $150.7 m. The company continues to report no revenue.

Cost-cutting reduced operating loss to $1.3 m for the quarter (-67% YoY) and $6.2 m for nine months (-48% YoY). Nine-month net loss narrowed to $9.8 m (FY24: $12.9 m). Cash used in operations improved to $4.5 m from $9.6 m, but financing inflows of $1.6 m and an additional $0.2 m bridge loan were not enough to stabilize liquidity.

Capital structure & dilution: Convertible debt totals $3.6 m; repricing clauses cut conversion prices to $0.335, materially increasing potential dilution. A debt-to-equity swap created a new Series H preferred class, exchanging $1.18 m of related-party notes for equity. Reverse split (1-for-40) became effective 19 Feb 2025; outstanding shares now 7.50 m.

Going-concern & listing issues: Management states substantial doubt remains due to limited cash and recurring losses. NYSE American suspended and commenced delisting on 29 Jan 2025 after the stock price collapsed, triggering a $624k default penalty on the Lind note.

Pending funding: A June 5, 2025 Securities Purchase Agreement with Goldeneye 1995 LLC could inject 1,000 BTC + $12-15 m cash, subject to extensive closing conditions targeted for Aug 2025.